Should You Use GMP to Decide on IPO Applications? (Data)

The most common mistake investors make with GMP is using it as the only signal. The second most common mistake is ignoring it entirely. This guide gives you a structured 5-step framework for incorporating GMP into IPO subscription decisions alongside the four other signals that matter.

GMP Decision Framework: Quick Reference

GMP Signal	QIB Subscription	Decision
GMP > 25%, rising trend	QIB > 10x	Strong apply signal - both signals aligned
GMP > 25%, rising trend	QIB < 5x	Be cautious - GMP may be inflated, wait for Day 3
GMP 10-25%, stable	QIB > 10x	Apply for moderate listing gain expectation
GMP 0-10%, flat or declining	Any	Apply on fundamentals only, not GMP
GMP negative	QIB < 3x	Skip - both signals against you
GMP negative	QIB > 10x	Rare - institutions know something; review fundamentals

The 5-Signal Framework for IPO Decisions

No single signal should drive an IPO subscription decision. The five signals that together give you a reliable picture:

1. GMP trend (7-day): Rising, stable, falling, or spike-then-decline. Direction matters more than level.
2. QIB subscription level: Is institutional money genuinely interested? 10x+ is meaningful; below 3x is a concern.
3. Anchor investor quality: Are domestic mutual funds (SBI MF, HDFC MF, Nippon, Mirae) in the anchor list?
4. Use of IPO proceeds: Fresh capital for growth (positive) vs Offer for Sale only (promoters selling out, negative).
5. Company fundamentals vs valuation: Does the PE / EV-EBITDA at issue price make sense relative to peers?

Think of this as a scorecard. 5 greens: apply with confidence. 4 greens: apply. 3 greens / 2 reds: apply only if you are comfortable with listing-day risk. 3+ reds: skip.

Step 1: Is GMP Positive or Negative?

This is the entry gate. If GMP has been negative for 3+ consecutive days before listing, the probability of a below-issue listing is above 80% based on historical data. A negative GMP screen should, by itself, prompt serious reconsideration.

If GMP is positive, proceed to the trend check. The level matters less than whether it is above or below zero.

Step 2: What is the 7-Day GMP Trend?

Apply the pattern framework:

• Rising consistently: positive signal, weight GMP green on your scorecard
• Stable at positive level: neutral-positive, weight as mild green
• Peak then declining: mixed signal, use settled level, weight as neutral
• Declining throughout: negative signal, weight as red even if current level is still positive

Step 3: Does QIB Subscription Align?

Check QIB subscription by day 2 of the IPO on NSE or BSE category-wise subscription data. If GMP is rising but QIB is below 5x, there is a divergence -- grey market is more excited than institutions. This is a yellow flag. If both are strong, that alignment is the most reliable setup for a strong listing.

The alignment check:

GMP Signal	QIB Subscription	Assessment
Rising / strong positive	10x+	Best case -- apply
Rising / strong positive	Under 5x	Yellow -- GMP may be operator-driven
Negative / falling	10x+	Institutions may be right, GMP may be wrong. Evaluate fundamentals.
Negative / falling	Under 5x	Worst case -- skip

Step 4: Is This Mainboard or SME?

If the IPO is an SME IPO, remove GMP entirely from your decision process. SME GMP is near-meaningless due to thin market and manipulation risk. Evaluate the company on: promoter track record, use of proceeds, sector quality, valuation vs listed peers, and whether any institutional investors participated as anchor investors.

For mainboard IPOs, proceed with the full 5-signal framework.

Step 5: What is Your Investment Thesis?

This step often gets skipped, but it determines how to weight all the signals above. Two different investment theses require different decision frameworks:

• Listing gain trade: You plan to sell on listing day. For this, GMP trend and QIB subscription are the most important signals. Fundamentals matter less; you are betting on short-term sentiment and allotment scarcity.
• Long-term hold: You want to own the business for 2-5 years. For this, company fundamentals and valuation are primary. GMP is nearly irrelevant -- many strong long-term businesses listed at flat or slight discounts. Evaluate the business as you would any stock purchase.

Mixing the two theses -- applying based on GMP but planning to hold if the listing disappoints -- is the worst outcome. Decide your thesis before you apply.

The Decision Matrix: Quick Reference

GMP Trend	QIB Sub	Domestic Anchors	Fresh Capital	Decision
Rising	10x+	Yes	Yes (50%+)	Apply with conviction
Rising	10x+	Yes	No (OFS heavy)	Apply for listing gain only; do not hold
Rising	3-10x	No	Any	Borderline -- evaluate fundamentals
Stable	5x+	Yes	Yes	Apply, lower conviction
Falling	Any	Any	Any	High risk -- consider skipping
Negative	Any	Any	Any	Skip unless strong fundamental case

When to Override GMP with Fundamentals

Two situations where fundamentals should override a weak GMP reading:

• Monopoly or near-monopoly businesses at reasonable valuations: A company with a 70% market share in a growing sector, listing at a reasonable PE, with strong promoter track record -- even flat GMP should not deter a long-term investor.
• Known macro tailwinds: Sectors with strong government spending or regulatory tailwinds (defence, railways, power infrastructure 2024-25 vintage) where the business quality is high and GMP is muted due to market conditions rather than company-specific weakness.

In both cases, GMP failing to excite the grey market does not mean the IPO is a bad investment -- it means listing day gains may be modest. If you are there for 3+ year returns, that is irrelevant.

Common Mistakes When Using GMP for IPO Decisions

• Applying to an SME IPO because GMP is 200% -- SME GMP is not a reliable signal
• Skipping an IPO because listing day GMP fell, when you planned to hold long-term anyway
• Using GMP without checking QIB subscription -- the two together are reliable; alone, each is weaker
• Acting on last-48-hour GMP spike without checking the 7-day trend -- could be short covering, not genuine demand

Frequently Asked Questions: Using GMP for IPO Decisions

Should I apply for an IPO based on GMP alone?

No. GMP is one of five signals - not a standalone reason to apply. The most reliable IPO decisions combine: (1) positive GMP above 20%, (2) QIB subscription above 10x, (3) fundamentally reasonable valuation, (4) fresh capital use of proceeds (not heavy OFS), and (5) clean promoter background. When all five align, the probability of a positive listing is substantially higher than any single signal alone.

How do I use GMP to decide how many lots to apply for?

GMP affects allotment probability indirectly. High GMP usually comes with high overall subscription, which reduces allotment odds. In heavily oversubscribed IPOs (100x+), most retail applicants receive at most 1 lot. Applying for more lots does not increase your chances - allotment is by lottery. The only variable you control is whether to apply or not, and via which account (family members can each apply for 1 lot independently).

What happens if GMP is high but the IPO does not list well?

This happens when: (1) GMP was inflated by grey market operators and not backed by genuine institutional demand, (2) market conditions deteriorated between subscription close and listing date, (3) QIB subscription was weak despite high GMP. Examples: Paytm IPO (GMP turned negative pre-listing, correctly called the crash), Ola Electric (GMP collapsed from ₹20 to zero before listing). When GMP falls sharply in the final 48 hours, it is a strong warning to manage expectations.